Professor Pawel Beczkowski
Asian, European and RCVS Recognised Specialist in Internal Medicine (Companion Animals)
Clinical Associate Professor
Office: Room 306, 3/F, Block 1B, To Yuen Building
Tel. no.: +852 3442-7220
Email: [email protected]
Web: CityU Scholars
Biography
Pawel received his DVM from Lublin University of Life Sciences, Poland in 2008. He also holds a Wellcome Trust funded PhD from the University of Glasgow. His research has focused on virus evolution in the progression of natural feline immunodeficiency virus infection.
Pawel has completed a clinical rotating internship at the Animal Health Trust and a residency in small animal internal medicine at the University of Glasgow. He is EBVS European and Royal College of Veterinary Surgeons Recognised Specialist in Companion Animals (Internal Medicine).
Prof. Beczkowski gained his research, clinical and teaching experience around the world and he always cherished the international collaborations in science and education. He has published and lectured widely and is passionate about infectious diseases and all aspects of small animal internal medicine.
Research
Prof. Beczkowski has a broad interest in companion animal virology, virus discovery, and cross-species transmission. His particular interest lies in the evolution of virus-host interactions with a view to pair it with clinical applications for the diagnosis, preventive strategies and treatment of viral diseases.
Selected Publication
- Beczkowski PM, Hughes J, Biek R, Litster A, Willett BJ, Hosie MJ. Feline immunodeficiency virus (FIV) env recombinants are common in natural infections. Retrovirology. 2014 Sep 17;11:80. DOI: 10.1186/s12977-014-0080-1
- Beczkowski PM, Hughes J, Biek R, Litster A, Willett BJ, Hosie MJ. Rapid evolution of the env gene leader sequence in cats naturally infected with feline immunodeficiency virus. J Gen Virol. 2015 Apr;96(Pt 4):893-903. DOI: 10.1099/vir.0.000035
- Beczkowski PM, Harris M, Techakriengkrai N, Beatty JA, Willett BJ, Hosie MJ. Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine. Vaccine. 2015 Feb 18;33(8):977-84. DOI: 10.1016/j.vaccine.2015.01.028
- Beczkowski PM, Techakriengkrai N, Logan N, McMonagle E, Litster A, Willett BJ, Hosie MJ. Emergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats. Retrovirology. 2014 Nov 28;11:95. DOI: 10.1186/s12977-014-0095-7
- Beczkowski PM, Logan N, McMonagle E, Litster A, Willett BJ, Hosie MJ. An investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virus. J Gen Virol. 2015 Mar;96(Pt 3):671-680. DOI: 10.1099/vir.0.071522-0
- Beczkowski PM, Litster A, Lin TL, Mellor DJ, Willett BJ, Hosie MJ. Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV). Vet Microbiol. 2015 Mar 23;176(1-2):50-60. DOI: 10.1016/j.vetmic.2014.12.023
- Hosie MJ, Techakriengkrai N, Beczkowski PM, Harris M, Logan N, Willett BJ. The Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans? Vet Sci. 2017 Jan 28;4(1):7. DOI: 10.3390/vetsci4010007